News

Innovation Business Breakfast

On October, 6, 2015 Comac Medical, as participant in Phase I of the Horizon 2020 SME Instrument, was invited to provide a presentation in a framework of a business breakfast of European Enterprise Network (EEN) – Bulgaria. The event was organized by Cleantech Bulgaria together with Green Business Network and the Applied Research and Communications Fund (ARC Fund).

The company was invited to share its valuable know-how, which contributed to the positioning of Bulgaria on the map of Horizon 2020 SME Instrument.

The event started with the presentation of Ms. Daniela Chonkova from Enterprise Europe Network Bulgaria & ARC Fund. She gave valuable insights on Horizon 2020 SME Instrument, revealing the opportunities the programme gives for innovation activities of Bulgarian companies. Ms. Mariana Hamanova – Director of Cleantech Bulgaria focused on the sustainable development issues and the new opportunities for the Bulgarian “Green Business”. Ms. Teodora Georgieva, chief expert of the Applied Research and Communications Fund, presented and gave further details on the Initiative of the European commission: “IMP³rove – Instrument for Innovation Management Assessment of SME”.

As a beneficiary of SME Instrument, Comac Medical was represented by Monika Panayotova and Tsvetomir Kadinov. They shared the experience of COMAC in different project phases – from the application process to the realization of the feasibility study on: “Improving diagnostics of respiratory diseases and boosting the Comac Medical competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device.”

As part of Comac Medical dissemination strategy, the representatives of the company shared valuable “recipes for success’’ which aimed at motivating more Bulgarian SMEs to participate in Horizon 2020 programme.

Comac Medical believes that business partnerships and knowledge sharing can not only help companies grow and internationalize their business but they can also contribute to the increased competitiveness of Bulgaria and the entire European Union in the global competition.

Share:
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...
The Bulgarian Drug Agency has announced reduced time periods for consideration of clinical trials on medicinal products for...